CollPlant (CLGN) Reports Q3 Loss of $0.35/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023
November 29, 2023 7:00 AM ESTReceived a $10 million milestone payment in the third quarter from partner, AbbVie Inc., for achieving a major milestone in the second quarter in accordance with the strategic collaboration agreement related to the clinical-phase dermal filler product candidateCompany is preparing to launch large-animal study with a commercial size breast implant by year-endCash and cash equivalents totaled $29 million as of September 30, 2023, representing an estimated cash runway of at least two yearsRevenues of $10.7 million and operating loss of $2.4 million for the first nine months... More
